What smart money is saying about Baxter International Inc.
No fund has written a full thesis on Baxter International Inc. in our archive, but 8 fund letters report a position in it, most recently Pzena IM Global Best Ideas Composite in September 2026.
Get an email when a fund buys, sells or pitches it
Fund signal · last 12 months
5 lettersToo few moves on Baxter International Inc. yet for a clear signal
Moves described in fund letters in our archive. A sentence published word for word by several funds of one house in the same quarter counts once.
Position history
Between Q1 2025 and Q3 2026, 8 fund letters reported a position in Baxter International Inc., with 3 buys (opened or added) and 2 sells (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1 | 0 |
| Q2 2026 | 1 | 1 | 0 | 0 |
| Q1 2026 | 1 | 0 | 1 | 0 |
| Q3 2025 | 2 | 2 | 0 | 0 |
| Q1 2025 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 9 positions · 5 moves
- September 2026
“Medical products company Baxter International rose after second-quarter results showed organic growth well ahead of expectations across all of its segments, led by its drug-compounding and intravenous (IV) solutions businesses, along with better-than- expected margins and improving free cash flow.”
Baxter International Inc. - September 2026
“Perrigo, NVIDIA, and Baxter were among the portfolio's best-performing securities in the quarter.”
Baxter International Inc. - September 2026
“The Fund experienced a maturity in Ford Motor Credit and we tendered the Fund’s position in Baxter International Inc.”
Baxter International Inc. - June 2026
“Select holdings in corporate bonds added to returns during the quarter, led by holdings in technology (Sabre Global and Pitney Bowes Inc.), pharmaceuticals (Organon and Baxter International), and communications (Fibercop and Univision Communications).”
Baxter International Inc. - New positionBrandes IP Core Plus Fixed Income FundJune 2026
“The Fund added new positions in Baxter International Inc. (5.162% coupon, maturing 12/1/51, rated Baa3/BBB-) and American National Group Inc. (7.00% coupon, hybrid security, call date 12/1/30, final maturity 12/1/55, rated BB+).”
Baxter International Inc. - March 2026
“l We eliminated the following position(s) during the period: • APA • Baxter • Celanese • Deere”
Baxter International Inc. - AddedPzena Focused ValueSeptember 2025
“Medical equipment manufacturer Baxter posted a disappointing earnings report driven by a voluntary recall for a recent product launch and a slower-than-expected recovery in demand for IV fluids – the product line that was disrupted last year by Hurricane Helene. We expect these issues to be transitory and view the stock price reaction as disproportionate relative to the magnitude of the earnings pressure, and we added to our position.”
Baxter International Inc. - September 2025
“Medical products company Baxter lowered its earnings guidance due to the lingering effects of Hurricane Helene and other operational issues. With a new CEO known for strong execution, we see meaningful self-help opportunities for earnings recovery and added to the position during the quarter.”
Baxter International Inc. - HoldsMacquarie Value FundMarch 2025
“Medical products maker Baxter International Inc. was another notable contributor.”
Baxter International Inc.
Read the letters behind these Baxter International Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→